-
ASAM Comment on OMB Proposal to Revise Federal Grant Rules
On July 13, the American Society of Addiction Medicine (ASAM) submitted a public comment to the White House Office of Management and Budget (OMB) in response to its proposed rule that would significantly alter Uniform Guidance governing federal grants, many of which are used to fund scientific research.Full story -
ASAM Recaps 2026 State Legislative Sessions with Mid-Year Report
The ASAM 2026 Mid-Year Report: Trends in Addiction Medicine State Legislation recaps major trends in addiction-related state policy.Full story -
ASAM Responds to HHS Request for Comment on the Chronic Disease of Addiction
On July 3, the American Society of Addiction Medicine (ASAM) submitted a letter to the Department of Health and Human Services (HHS) in response to its request for information (RFI) on the chronic disease of addiction.Full story -
The ASAM Weekly for July 7, 2026
From the rescheduling of cannabis and the surging prevalence of nicotine pouches like Zyn, to the structural setbacks face-to-face with the alcohol industry, our field is moving at a breakneck pace.Full story -
ASAM Welcomes Reintroduction of Bipartisan Legislation to Expand Medicare Coverage for Residential Addiction Treatment
Full story -
MASAM Supports Strong Health and Safety Regulation of Kratom Products
Full story -
The ASAM Weekly for June 30, 2026
One last commentary as EIC.Full story -
ASAM Applauds Bipartisan Legislation to Expand Access to Methadone Treatment for Opioid Use Disorder
Full story -
The ASAM Weekly for June 23, 2026
Social Media Use Trajectories and Substance Use ExperimentationFull story -
Guest Editorial – Stigma, Pity, and the Limits of Empathy
Explore the limits of empathy in healthcare. Learn how peer mentor O’Nesha Cochran’s lived experience challenges stigma and helps providers honor patient dignity.Full story -
The ASAM Weekly for June 16, 2026
Inclusion criteriaFull story -
MISAM Comments on Legislation Allowing Opioid Settlement Dollars to Fund Ibogaine Research
Full story -
The ASAM Weekly for June 9, 2026
EndtroducingFull story -
Dr. Smita Das Appointed Editor in Chief of The ASAM Weekly Newsletter
Full story -
FAQ: Medicaid Community Engagement Requirements — What New Rules Mean for Patients with a Substance Use Disorder
Full story -
The ASAM Weekly for June 2, 2026
Too much of a good thingFull story -
ASAM Statement: CMS Interim Final Rule on the Medicaid Community Engagement Requirement
Full story -
Guest Editorial – Using Human-in-the-Loop AI to Understand Stigma During the Deployment of Addiction Evidence-Based Practices in the HEALing Communities Study
Medications for opioid use disorder (MOUD), and overdose education and naloxone distribution (OEND), are among the most supported evidence-based practices (EBPs) in addiction medicine. Yet the real-world deployment of those EBPs at scale in diverse communities remains limited. Research shows that stigma toward these EBPs, toward people who use drugs or people receiving MOUD, plays a significant role in limiting the deployment and use of these EBPs in communities impacted by the opioid crisis.Full story -
The ASAM Weekly for May 26, 2026
Too much of a good thingFull story -
MASAM Supports Proposed Legislation Adding Methadone to the PMP
Full story